Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gillian Murtagh
Observed names:
G. Murtagh,
GILLIAN MURTAGH
Institution:
BridgeBio (United States)
Observed institutions:
Abbott (United States),
BridgeBio (United States),
Wake Forest University Health Sciences,
Wake Forest University
ORCID:
0009-0001-4900-3080
Observed ORCID:
0009-0001-4900-3080
OpenAlex ID:
A5073683692
Circulating Cardiovascular Biomarkers in Cancer Therapeutics‐Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions
2023
·
Gillian Murtagh
, James L. Januzzi
, et al.
·
Journal of the American Heart Association
·
63
PDF
Reduced Congestion and Improved Response to a Fluid/Sodium Challenge in Chronic Heart Failure Patients After Initiation of Sacubitril/Valsartan: The NATRIUM-HF Study
2024
·
Alexandre Mebazaa
, Beth A. Davison
, et al.
·
European Journal of Heart Failure
·
30
PDF
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
2025
·
Frederick L. Ruberg
, Sergio Teruya
, et al.
·
JAMA Cardiology
·
28
PDF
High Sensitivity Troponin Level and Benefits of Chronic Total Occlusion Revascularization
2023
·
Daniel A. Gold
, Pratik B. Sandesara
, et al.
·
Journal of the American Heart Association
·
6
PDF
Differentiating Type 1 and Type 2 myocardial infarction using a machine learning algorithm and biomarkers
2025
·
Anna Snavely
, Laurel Jackson
, et al.
·
The American Journal of Emergency Medicine
·
5
Machine learning to risk stratify chest pain patients with non-diagnostic electrocardiogram in an Asian emergency department
2025
·
Ziwei Lin
, Tar Choon Aw
, et al.
·
Annals of the Academy of Medicine Singapore
·
3
Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CM
2026
·
BRETT W. SPERRY
, AHMAD MASRI
, et al.
·
Journal of Cardiac Failure
·
2
PDF
Patient-Reported Benefits of Acoramidis Across Genotypes in Transthyretin Amyloid Cardiomyopathy: KCCQ and EQ-5D-5L Outcomes From ATTRibute-CM
2026
·
EMER JOYCE
, AHMAD MASRI
, et al.
·
Journal of Cardiac Failure
·
1
Abstract 4148199: Enhanced Diagnostic Value of High Sensitivity Troponin I After Indexation for Myocardial Mass, Renal Function and Age: the BioHEART-CT Study
2024
·
Sina Fathieh
, Michael Patrick Gray
, et al.
·
Circulation
·
1
Natriuretic Peptide and Transthyretin and Their Relationship With Clinical Outcomes: Results From ATTRIBUTE‐CM, a Randomized Controlled Trial
2026
·
Onyedika John Ilonze
, Daniel Philip Judge
, et al.
·
Journal of the American Heart Association
Plain language summary of how acoramidis affects the total number of heart problems over time in people with ATTR-CM: findings from the ATTRibute-CM study
2026
·
Ahmad Masri
, Daniel P. Judge
, et al.
·
Future Cardiology
PDF
15 Diagnostic Performance of the MI3 Machine Learning Algorithm in Patients With an Initial Indeterminate Troponin
2024
·
S. Mahler
, A. Snavely
, et al.
·
Annals of Emergency Medicine
Abstract 13874: N Terminal Pro-Brain Natriuretic Peptide Levels and Benefits of Chronic Total Occlusion Revascularization
2023
·
Daniel A Gold
, Pratik B Sandesara
, et al.
·
Circulation
(52) High Sensitivity Troponin-I is Associated with Acute Rejection in Pediatric Heart Transplant Recipients
2023
·
D.A. Magnetta
, L. Jackson
, et al.
·
The Journal of Heart and Lung Transplantation
Show more works
View as search
Works count:
14
Citation count:
139
H-index:
5
I10-index:
3
Year
Topic
Type